Medicinal Product Shortages – update – 27 April 2022

Notice type: Advisory

Date: 27/04/2022


Further Information:

 The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Aciclovir 25mg/ml Concentrate for Solution for Infusion (20ml presentation only) - PA0822/215/001
  • Aldactone 25mg Film Coated Tablets - PA0822/110/001
  • Aldactone 50mg Film Coated Tablets - PA0822/110/002
  • Azithromycin Clonmel 250mg Film Coated Tablets - PA0126/150/001
  • Gemcitabine Actavis 40mg/ml Concentrate for Solution for Infusion (50ml presentation only) - PA1380/182/001
  • Molipaxin 50mg Hard Capsules - PA540/056/001
  • Nebido 1000mg/4 ml, Solution for Injection - PA1410/020/001
  • Ogivri 150mg Powder for Concentrate for Solution for Infusion - EU/1/18/1341/001
  • Spironolactone 25mg Film Coated Tablets - PA2315/119/001
  • Tenofovir disoproxil Mylan 245mg Film Coated Tablet - EU/1/16/1129/001
  • Ultiva 5mg Powder for Concentrate for Solution for Infusion - PA1691/032/003
  • Zinnat 500mg Film Coated Tablets - PA1077/015/003


The following shortages have been resolved and supply has resumed to the Irish market:

  • Cozatan 50mg Film Coated Tablets - PA0126/167/001
  • Cozatan 100mg Film Coated Tablets - PA0126/167/002
  • Cozatan Comp 100mg/25mg Film Coated Tablets - PA0126/184/002
  • Cozatan Comp 50mg/12.5mg Film Coated Tablets - PA0126/184/001
  • Januvia 25mg Film Coated Tablets - EU/1/07/383/002
  • Navelbine 20mg Capsules - PA0329/011/001
  • Pabal 100mcg/ml, Solution for Injection - PA1009/021/001
  • Telfast Allergy 120mg Film Coated Tablets - PA23180/014/001
  • Tracrium 10mg/ml, Solution for Injection or Infusion - PA1691/029/002
  • Xarelto 1mg/ml Granules for Oral Suspension - EU/1/08/472/050-051


Please see the shortages section of the HPRA website for further information.

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

« Back